QC
ARKG icon

Quadrature Capital’s ARK Genomic Revolution ETF ARKG Stock Holding History

Quadrature Capital’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-77,072
Closed -$2.23M – 1358
2025
Q4 		$2.23M Buy
77,072
+29,044
+60% +$872K 0.02% 347
2025
Q3 		$1.33M Buy
+48,028
New +$1.21M 0.02% 350
2025
Q1 		– Sell
-23,826
Closed -$561K – 1060
2024
Q4 		$561K Sell
23,826
-53,097
-69% -$1.31M 0.01% 557
2024
Q3 		$1.97M Buy
+76,923
New +$1.96M 0.04% 252

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Quadrature Capital's ARKG Position: Q1 2026 in Review

Quadrature Capital sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 77,072 shares — an estimated $2.23M sold.

Quadrature Capital first reported a position in ARKG in Q3 2024 and held it in 4 quarters. The position peaked at $2.23M in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Quadrature Capital reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • Quadrature Capital sold 77,072 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $2.23M.
  • Quadrature Capital first reported a position in ARK Genomic Revolution ETF in Q3 2024 and held it in 4 quarters.
  • Quadrature Capital's ARK Genomic Revolution ETF position peaked at $2.23M in Q4 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Quadrature Capital's 13F filing for Q1 2026, filed 15 May 2026.